Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 22

1.

Vascular integrins: therapeutic and imaging targets of tumor angiogenesis.

Rüegg C, Alghisi GC.

Recent Results Cancer Res. 2010;180:83-101. doi: 10.1007/978-3-540-78281-0_6. Review.

PMID:
20033379
2.

Integrins in cancer: biological implications and therapeutic opportunities.

Desgrosellier JS, Cheresh DA.

Nat Rev Cancer. 2010 Jan;10(1):9-22. doi: 10.1038/nrc2748. Review.

3.

Radionuclide imaging of tumor angiogenesis.

Dijkgraaf I, Boerman OC.

Cancer Biother Radiopharm. 2009 Dec;24(6):637-47. doi: 10.1089/cbr.2009.0694. Review.

PMID:
20025543
4.

Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinoma.

Yu M, Zhou H, Liu X, Huo Y, Zhu Y, Chen Y.

Ann Nucl Med. 2010 Jan;24(1):13-9. doi: 10.1007/s12149-009-0328-3. Epub 2009 Dec 9.

PMID:
19997991
5.

Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT).

Kossodo S, Pickarski M, Lin SA, Gleason A, Gaspar R, Buono C, Ho G, Blusztajn A, Cuneo G, Zhang J, Jensen J, Hargreaves R, Coleman P, Hartman G, Rajopadhye M, Duong LT, Sur C, Yared W, Peterson J, Bednar B.

Mol Imaging Biol. 2010 Oct;12(5):488-99. doi: 10.1007/s11307-009-0279-z. Epub 2009 Dec 4.

PMID:
19960268
6.

Integrins: masters and slaves of endocytic transport.

Caswell PT, Vadrevu S, Norman JC.

Nat Rev Mol Cell Biol. 2009 Dec;10(12):843-53. doi: 10.1038/nrm2799. Review.

PMID:
19904298
7.

New targeted probes for radioimaging of angiogenesis.

Stollman TH, Ruers TJ, Oyen WJ, Boerman OC.

Methods. 2009 Jun;48(2):188-92. doi: 10.1016/j.ymeth.2009.03.006. Epub 2009 Mar 24. Review.

PMID:
19318127
8.

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression.

Dijkgraaf I, Beer AJ, Wester HJ.

Front Biosci (Landmark Ed). 2009 Jan 1;14:887-99. Review.

PMID:
19273106
9.

Imaging of integrin alphavbeta3 expression.

Beer AJ, Schwaiger M.

Cancer Metastasis Rev. 2008 Dec;27(4):631-44. doi: 10.1007/s10555-008-9158-3. Review.

PMID:
18523730
10.

Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature.

Schnell O, Krebs B, Wagner E, Romagna A, Beer AJ, Grau SJ, Thon N, Goetz C, Kretzschmar HA, Tonn JC, Goldbrunner RH.

Brain Pathol. 2008 Jul;18(3):378-86. doi: 10.1111/j.1750-3639.2008.00137.x. Epub 2008 Apr 2.

11.

Optical imaging: current applications and future directions.

Luker GD, Luker KE.

J Nucl Med. 2008 Jan;49(1):1-4. Epub 2007 Dec 12. Review.

12.

A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.

Lim EH, Danthi N, Bednarski M, Li KC.

Nanomedicine. 2005 Jun;1(2):110-4. Review. No abstract available.

PMID:
17292065
13.
14.

Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.

Dijkgraaf I, Kruijtzer JA, Liu S, Soede AC, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC.

Eur J Nucl Med Mol Imaging. 2007 Feb;34(2):267-73. Epub 2006 Aug 15.

PMID:
16909226
15.

Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx.

Weller GE, Villanueva FS, Tom EM, Wagner WR.

Biotechnol Bioeng. 2005 Dec 20;92(6):780-8.

PMID:
16121392
16.

Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction.

Sillerud LO, Larson RS.

Curr Protein Pept Sci. 2005 Apr;6(2):151-69. Review.

PMID:
15853652
17.

Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosis.

Coleman PJ, Brashear KM, Askew BC, Hutchinson JH, McVean CA, Duong LT, Feuston BP, Fernandez-Metzler C, Gentile MA, Hartman GD, Kimmel DB, Leu CT, Lipfert L, Merkle K, Pennypacker B, Prueksaritanont T, Rodan GA, Wesolowski GA, Rodan SB, Duggan ME.

J Med Chem. 2004 Sep 23;47(20):4829-37.

PMID:
15369386
18.

Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives.

Wang J, Breslin MJ, Coleman PJ, Duggan ME, Hunt CA, Hutchinson JH, Leu CT, Rodan SB, Rodan GA, Duong LT, Hartman GD.

Bioorg Med Chem Lett. 2004 Feb 23;14(4):1049-52.

PMID:
15013021
19.

Development of radiocontrast agents for vascular imaging: progress to date.

Blankenberg FG, Mari C, Strauss HW.

Am J Cardiovasc Drugs. 2002;2(6):357-65. Review.

PMID:
14727951
20.

A submillimeter resolution fluorescence molecular imaging system for small animal imaging.

Graves EE, Ripoll J, Weissleder R, Ntziachristos V.

Med Phys. 2003 May;30(5):901-11.

PMID:
12772999

Supplemental Content

Support Center